 |
|
|
 |
.NEWS FROM SIO
SIO Submits Recommendations to NCCN Panel for Hepatobiliary Cancer
The Society of Interventional Oncology submitted updates to the NCCN hepatobiliary guidelines. Submitted by Gregory Nadolski, MD, Assistant Professor, University of Pennsylvania, Sid Padia, MD, Associate Professor, UCLA, and Beau Toskich, MD, Radiologist, Mayo Clinic. This letter requests the NCCN Guidelines Panel for Hepatobiliary Cancer review five specific changes and data regarding the treatment of HCC. Download the complete letter here.
|
|
Women Leaders in Academic Research Webinar Series
Next Week, attend "Re-Thinking Mentoring: Perspectives from a Biomedical Engineer," the latest installment of the Women Leaders in Academic Research series by NIH. Jenna Mueller, PhD, will explore re-thinking mentoring on 28 September from 2:00 p.m. – 3:00 p.m ET.
This invited monthly lecture series highlights & honors women leaders in academic research, especially related disciplines of Interventional Radiology, Biomedical Engineering, Radiology, Imaging Sciences, Data Science, & Image-Guided Oncology. The honorary lecture series was established by the NIH Center for Interventional Oncology as a small effort to help counter the under-representation of women in academic research & the impact of gender disparity & implicit bias on role modeling and mentoring. Monthly topics are open-ended & are geared towards highlighting successful female or other under-represented academic leaders, as role models for trainees.
|
|
New Research Guidelines Will Boost Interventional Oncology Research
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty. Learn more about these new guidelines, a collaboration between SIO and the Definition for the Assessment of Time-to-event Endpoints in Cancer (DATECAN) trials initiative.
|
|
IO Awareness Week
The inaugural IO Awareness Week takes place 25-31 October 2021, and we can't wait to celebrate our dedicated Interventional Oncology community while spreading the word of IO. Subscribe to our dedicated Social media accounts to stay tuned as we get ready to kick off our brand-new website coming soon!
Facebook
LinkedIn
Twitter
|
|
|
|
 |
|
Outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation System from the OPuS One trial were recently published in the November edition of the Journal of Vascular and Interventional Radiology (JVIR). Learn more about the largest prospective study in radiofrequency ablation for bone metastases.
|
|
Access Funding and Exclusive Events with the SIO2022 IO Essentials Scholarship!
Don't forget to apply for the IO Essentials Scholarship at the SIO2022 Annual Scientific Meeting! Take advantage of this opportunity to access top-tier education, networking opportunities with IO luminaries and continued professional development.
Scholarship applications are due on Friday, 1 October.
What Does the Scholarship Include?
- Stipend for travel expenses to the SIO2022 Annual Scientific Meeting ($200 local, $750 North America, and $1,000 international applicants)
- One year of complimentary membership to SIO
- Invitation to the IO Essentials Program taking place Thursday, 3 February.
- Exclusive invitations to events with industry leaders
Not a Resident?
Share this opportunity! Applicants must be in their ACGME diagnostic radiology residency at the time of application, or be a post-graduate medical student within the IO field.
Visit the SIO website to learn more and to reserve your spot at SIO2022!
|
|
|
|
|
Abstracts for SIO2022 Due Next Week 
One week remains to submit abstracts for the SIO 2022 Annual Scientific Meeting in San Francisco, California, 3-7 February! This is your opportunity to showcase your research, whether in-person or via virtual poster options.
Share your research with more than 600 professionals in the global IO community and gain recognition from your peers. Abstracts may be submitted for an oral or poster presentation on one of the following topics:
- Basic Science
- Genitourinary
- Guidance & Targeting
- HCC
- Imaging
- Liver Metastases
- Technology
- Thoracic
- Education
- Other
NEW THIS YEAR! While SIO does not have a policy that limits prior presentation of data, we are excited to host IO abstracts submitted and presented for the first time in a scientific meeting in the SIO Debut Presentations session. For this inaugural session, we encourage you to submit trials or studies presenting data on first release for consideration.
The deadline to submit your abstract will be 30 September 2021.
|
|
.INDUSTRY NEWS
Portal vein tumor thrombosis and hepatocellular carcinoma — the changing tides
Journal of Hepatocellular Carcinoma via PubMed
Portal vein involvement is considered one of the most fearful complications of hepatocellular carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor biology (high grade), high tumor burden (number and size of lesions), high levels of serum markers (AFP), poor liver function (deranged LFT), and poor performance status of patients.
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063 |
